These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17681816)

  • 1. In vivo imaging of disturbed pre- and post-synaptic dopaminergic signaling via arachidonic acid in a rat model of Parkinson's disease.
    Bhattacharjee AK; Meister LM; Chang L; Bazinet RP; White L; Rapoport SI
    Neuroimage; 2007 Oct; 37(4):1112-21. PubMed ID: 17681816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-Amphetamine stimulates D2 dopamine receptor-mediated brain signaling involving arachidonic acid in unanesthetized rats.
    Bhattacharjee AK; Chang L; White L; Bazinet RP; Rapoport SI
    J Cereb Blood Flow Metab; 2006 Nov; 26(11):1378-88. PubMed ID: 16511499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic lithium chloride administration to unanesthetized rats attenuates brain dopamine D2-like receptor-initiated signaling via arachidonic acid.
    Basselin M; Chang L; Bell JM; Rapoport SI
    Neuropsychopharmacology; 2005 Jun; 30(6):1064-75. PubMed ID: 15812572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic d-amphetamine depresses an imaging marker of arachidonic acid metabolism in rat brain.
    Bhattacharjee AK; Chang L; Chen M; White L; Bell JM; Bazinet RP; Rapoport SI
    Int J Neuropsychopharmacol; 2008 Nov; 11(7):957-69. PubMed ID: 18570702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D2 but not D1 dopamine receptor stimulation augments brain signaling involving arachidonic acid in unanesthetized rats.
    Bhattacharjee AK; Chang L; Lee HJ; Bazinet RP; Seemann R; Rapoport SI
    Psychopharmacology (Berl); 2005 Aug; 180(4):735-42. PubMed ID: 16163535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic carbamazepine administration attenuates dopamine D2-like receptor-initiated signaling via arachidonic acid in rat brain.
    Basselin M; Chang L; Chen M; Bell JM; Rapoport SI
    Neurochem Res; 2008 Jul; 33(7):1373-83. PubMed ID: 18302021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective dopamine receptor stimulation differentially affects [3H]arachidonic acid incorporation, a surrogate marker for phospholipase A2-mediated neurotransmitter signal transduction, in a rodent model of Parkinson's disease.
    Hayakawa T; Chang MC; Rapoport SI; Appel NM
    J Pharmacol Exp Ther; 2001 Mar; 296(3):1074-84. PubMed ID: 11181943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
    Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging apomorphine stimulation of brain arachidonic acid signaling via D2-like receptors in unanesthetized rats.
    Bhattacharjee AK; Chang L; White L; Bazinet RP; Rapoport SI
    Psychopharmacology (Berl); 2008 May; 197(4):557-66. PubMed ID: 18274730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intraaccumbens microinjections of quinopirole on head turning and circling movement in the rat.
    Crescimanno G; Emmi A; Amato G
    Pharmacol Biochem Behav; 1998 Aug; 60(4):829-34. PubMed ID: 9700965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats.
    Ramadan E; Basselin M; Taha AY; Cheon Y; Chang L; Chen M; Rapoport SI
    Neuropharmacology; 2011 Dec; 61(8):1256-64. PubMed ID: 21839100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease.
    Löschmann PA; Wüllner U; Heneka MT; Schulz JB; Kunow M; Wachtel H; Klockgether T
    Synapse; 1997 Aug; 26(4):381-91. PubMed ID: 9215597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
    Bentlage C; Nikkhah G; Cunningham MG; Björklund A
    Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
    Murer MG; Dziewczapolski G; Menalled LB; García MC; Agid Y; Gershanik O; Raisman-Vozari R
    Ann Neurol; 1998 May; 43(5):561-75. PubMed ID: 9585350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral effects of 5-HT2C receptor antagonism in the substantia nigra zona reticulata of the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Fox SH; Moser B; Brotchie JM
    Exp Neurol; 1998 May; 151(1):35-49. PubMed ID: 9582253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.
    Hu XT; Wachtel SR; Galloway MP; White FJ
    J Neurosci; 1990 Jul; 10(7):2318-29. PubMed ID: 1973947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
    Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Turgeon SM; Fink JS
    Neuroscience; 1997 Jul; 79(1):79-93. PubMed ID: 9178866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knocking out the dopamine reuptake transporter (DAT) does not change the baseline brain arachidonic acid signal in the mouse.
    Ramadan E; Chang L; Chen M; Ma K; Hall FS; Uhl GR; Rapoport SI; Basselin M
    Int J Neurosci; 2012 Jul; 122(7):373-80. PubMed ID: 22376027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging.
    Chen YC; Choi JK; Andersen SL; Rosen BR; Jenkins BG
    Psychopharmacology (Berl); 2005 Aug; 180(4):705-15. PubMed ID: 15536545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.